Table of Contents
ISRN Spectroscopy
Volume 2013, Article ID 361385, 6 pages
Research Article

A Stability Indicating Assay Method Development and Validation for the Frovatriptan Succinate Monohydrate by Using UV: A Spectrophotometric Technique

School of Pharmaceutical Sciences, Lovely Faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India

Received 6 March 2013; Accepted 10 April 2013

Academic Editors: W. A. Badawy, I. P. Gerothanassis, and X. Shi

Copyright © 2013 Hitesh Verma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Kelman, “Review of frovatriptan in the treatment of migraine,” Journal of Neuropsychiatric Disease and Treatment, vol. 4, no. 1, pp. 49–54, 2008. View at Google Scholar · View at Scopus
  2. E. A. Balbisi, “Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine,” Journal of Therapeutics and Clinical Risk Management, vol. 2, no. 3, pp. 303–308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. T. Hansen, “Frovatriptan for acute treatment of migraine,” European Journal of Neurology, vol. 6, no. 4, pp. 262–264, 2011. View at Google Scholar
  4. S. K. Acharjya, P. Mallick, P. Panda, and M. M. Annapurna, “Spectrophotometric methods for the determination of Frovatriptan succinate monohydrate in bulk and Pharmaceutical dosage forms,” International Journal of Pharmacy and Technology, vol. 2, no. 3, pp. 565–576, 2010. View at Google Scholar
  5. S. K. Acharjya, P. Panda, P. Mallick, and M. M. Annapurna, “Validated spectrophotometric methods for determination of Frovatriptan Succinate Monohydrate in pharmaceutical dosage forms,” Der Pharmacia Lettre, vol. 2, no. 4, pp. 452–460, 2010. View at Google Scholar
  6. N. U. Rani, R. S. Rao, K. Saraswathi, and T. E. G. K. Murthy, “RP-HPLC and spectrophotometry method for the analysis of frovatriptan in formulations,” International Journal of Science Innovations and Discoveries, vol. 1, no. 1, pp. 53–61, 2011. View at Google Scholar
  7. S. G. Kumara, J. M. R. Kumar, J. V. L. N. S. Rao, and D. V. Kumar, “Development and validation of RP-HPLC method for the estimation of frovatriptan succinate in bulk and tablet dosage form,” Journal of Pharmacy Research, vol. 52, no. 2, pp. 894–895, 2012. View at Google Scholar
  8. L. Laugher, R. Briggs, J. Doughty, and T. A. G. Noctor, “Development of an analytical methodology from toxicokinetic to clinical studies for the anti-migraine drug frovatriptan,” Chromatographia, vol. 52, pp. S113–S119, 2000. View at Google Scholar · View at Scopus
  9. S. Boltan and C. Bon, Pharmaceutical Statistics Practical and Clinical Applications, Informa Healthcare, New York, NY, USA, 5th edition, 2010.
  10. A. F. Aubry, P. Tattersall, and J. Ruan, “Development of stability indicating methods,” in Handbook of Stability Testing in Pharmaceutical Development Regulation, Methodologies and Best Practice, H. B. Kim, Ed., pp. 146–149, Springer, New York, NY, USA, 1st edition, 2009. View at Google Scholar
  11. P. C. Meier and E. R. Zünd, Statistical Methods in Analytical Chemistry, John Wiley & Sons, Toronto, Canada, 2nd edition, 2000.